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Summary
An association has recently been suggested between
several of the genes and proteins that play a central
role in early neuronal development, particularly in neu-
ronal migration and axon elongation, and Alzheimer’s
disease (AD). This paper reviews the work of several
investigators who have hypothesised the involvement
of three pathways known to be active participants in
neuronal maturation (those involving Notch, Reelin,
and Wnt intracellular signalling) and also in the neu-
rodegenerative events underlying AD. The choice of
these intracellular pathways is based on the observa-
tion that there exist several points of convergence
among these systems and amyloid precursor protein
processing and neurofibrillary tangle formation. Phar-
macological manipulation of the Notch/Wnt/Reelin in-
tracellular signalling pathways may thus represent a
novel approach to the regulation of neurodegenerative
processes in AD.
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Introduction
Alzheimer’s disease (AD) involves a progressive de-
generation of selective neuronal subpopulations in
cerebral and limbic cortices. Characteristic, although
not exclusive, neuropathological hallmarks of AD are
aggregated proteins in the form of intraparenchymal
amyloid plaques or intracellular neurofibrillary tangles
(NFTs) (1,2), as well as astrogliosis and microgliosis.
The plaques are predominantly composed of a 40/42
amino acid peptide, defined amyloid β-peptide (Aβ) ,
which is derived from the proteolysis of the amyloid pre-
cursor protein (APP) by enzymes called beta- and gam-
ma-secretase ( β- and γ-secretase), whereas NFTs are
bundles of paired helical filaments composed of the mi-
crotubule-associated protein tau.
One of the most widely accredited working hypotheses
is that excessive formation and deposition of Aβ by its
precursor APP is responsible for the neuronal loss/dys-
function that leads eventually to dementia. Notably, fa-
milial AD frequently results from mutations in the gene
encoding APP or in genes encoding presenilins (PSs),
which are involved in APP processing. Despite making
considerable progress in understanding of the genetic
and molecular basis of AD amyloidosis, researchers in
the field have still to demonstrate that interference with
plaque formation (by drugs or vaccine) constitutes a
valid disease-modifying approach. An additional feature
of the AD brain is the presence of dystrophic neurites,
numerous contorted processes from cell bodies of NFT-
bearing neurons and supernumerary basilar dendrites
on hippocampal pyramidal cells. These observations
suggest that AD may also be associated with an aber-
rant neural plasticity, understood, in more general
terms, as an ability of selected neuronal cells to change
morphology, including synaptic contacts.
In one particularly exciting line of research in the field,
several of the genes and proteins associated with AD
have been found to play a central role in early neuronal
development, particularly neuronal migration and axon
elongation. Many investigators have picked up on the
potential significance of this observation, although a
clear picture of the link between neurodevelopment and
neurodegeneration has yet to emerge.
The pathfinder Reelin
Recent acquisitions in the study of physiological and
pathological processes in the nervous system seem to
paint a paradoxical picture of neuronal development
and degenerative behaviour. The suggestion, based on
an increasing number of observations, is that proteins
formerly known as pro-differentiating molecules can be
involved in neurodegenerative disorders, mainly AD.
For example, it is known that the orderly migration of
neuronal precursors from the ventricular germinal zone
beneath the cortical plate to the outermost layer of the
cortex is somehow guided by a protein called Reelin
(3). This molecule is physiologically secreted by the Ca-
jal-Retzius cells along the guiding track of the radial
glia. In the absence of Reelin, migrating neurons fail in
their attempt to reach the final cortical location and pile
up in a disordered manner. The ability of Reelin to drive
neuroblast migration and then differentiation is due to a
membrane protein multi-complex capable of transduc-
ing Reelin binding in an intracellular signal, which is di-
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rected down to the cytoskeleton and nucleus. In partic-
ular, along the signal cascade an adaptor protein called
Disabled (Dab) becomes tyrosine phosphorylated, most
probably by the non-receptor tyrosine kinase Abl. At
present, very little is known about downstream targets
of activated Dab. Interestingly, mutations in the cyclin-
dependent kinase-5 (cdk5) gene produce defects in
neuronal migration that resemble those caused by loss
of the Reelin signal, thus proposing cdk5 as one of its
potential effectors. Additionally, this kinase has been
shown to be an important mediator of tau phosphoryla-
tion, hyperphosphorylated tau being typically abundant
in NFTs. Although hypothesized, the idea that Reelin
and APP signalling pathways may converge has not yet
been fully explored.
It has recently been demonstrated that Reelin is a ser-
ine protease and that it induces detachment of cells
from fibronectin- or laminin-coated substrates, thereby
supporting the hypothesis that Reelin could modulate
neuronal migration in the developing brain by regulat-
ing cell adhesion (4). In view of the recently discovered
proteolytic activity of Reelin, one working hypothesis is
that Reelin may be involved in the proteolytic process-
ing of APP, or in the clearance of A β aggregates gen-
erated by APP processing. This hypothesis is support-
ed by the following observations: a) both Reelin and
APP are expressed during early embryogenesis as well
as in the adult nervous system, and they trigger com-
mon intracellular signalling pathways involving adaptor
proteins such as Dab and Ab1. Additionally, the Dab1-
knockout mice phenotype includes neuronal migration
disorders resembling the reeler phenotype (5); b) Reel-
in is a secreted serine protease, and the extracellular
portion of two APP isoforms contains a serine protease
inhibitor domain of the Kunitz type (KPI domain); c) i n
v i t r o studies suggest that both membrane-bound and
soluble APP promote neuronal migration and neurite
extension; d) double-transgenic mice that express both
human mutant APP and human mutant PS1 show ac-
cumulation of Reelin in AD-typical plaques in the hip-
pocampus and neocortex (6). Together, these observa-
tions suggest an interplay between APP and Reelin
f u n c t i o n s .
The Notch gene family
The Notch gene family has four members (Notch1,
Notch2, Notch3, Notch4) encoding cell surface recep-
tors involved in a wide variety of cellular interactions
that determine cell fate during development. During
neuronal differentiation, upon ligand-induced activation,
this ubiquitous type I membrane family receptor under-
goes a proteolytic cleavage of the intramembrane-
spanning segment, releasing the intracellular domain.
This fragment translocates into the nucleus where it is
able to transactivate several genes involved in axon
outgrowth and differentiation. Furthermore, Notch coop-
erates with Abl and other unknown tyrosine kinases to
directly control growth cone motility and guidance, and
this effect seems to be mediated by recruitment of Dab
adaptor protein and Rho family GTPases, mainly Rac.
Interestingly, the phenotype of PS1 knockout mice re-
sembles that of Notch1 knockout mice (7) and the ex-
pression of Notch1 and its ligand Delta-like1 is dimin-
ished in the paraxial mesoderm of PS1 null embryos
(8). These findings suggest that PS1 may regulate the
Notch signalling pathway during development. More-
over, a possible involvement of the Notch family pro-
teins in AD has been suggested. In fact, it has been
shown that both Notch1 and APP can be cleaved by a
PS1-associated γ-secretase activity (9,10), and Notch1
expression is markedly increased in AD hippocampal
formation (11). Furthermore, Notch3 gene mutations
can lead to CADASIL, an adult-onset autosomal domi-
nant neurological disease characterized by progressive
subcortical infarcts and dementia (12). Finally, Notch2
was found to be upregulated in an experimental model
of excitotoxicity (13).
Recent in vitro studies of neurons from mouse cerebral
cortex revealed that contact-mediated Notch signalling
regulates the capacity of neurons to extend and elabo-
rate neuritis (14). Up-regulation of Notch1 and Notch2
activity was indeed concomitant with an increased
number of interneuronal contacts and cessation of
neurite growth. Given that members of the Notch sig-
nalling pathway are expressed in neurons in the adult
cerebral cortex, it is plausible that Notch plays a role in
maintaining the stability of neuritis and connections.
Thus, it is possible that an alteration of Notch activity
(perhaps as a result of PS dysfunction) would con-
tribute to aberrant neurite formation, such as that seen
in the AD brain.
The Wnt pathway
Another molecule known to be involved in neuronal dif-
ferentiation, adhesion and cell-fate is Wnt.
Upon interaction with specific membrane receptors
such as Frizzleds (Fzd), Wnt activates the mammal ho-
mologue of Drosophila dishevelled protein, Dv1, there-
by disabling glycogen-synthase kinase-3β ( G S K - 3β) .
As a result of GSK-3β inactivation, intracellular levels of
β-catenin, an Armadillo repeat-containing protein in-
volved in cell adhesion, increases so that Wnt target
genes are activated. In the absence of Wnt, GSK-3β is
activated, causing the phosphorylation of β-catenin and
in turn its ubiquitin-proteasome mediated degradation
with suppression of Wnt-related gene transcription. In-
terestingly, PS1 was found to interact both with β-
catenin (stabilizing it) and GSK-3β. This latter interac-
tion seems to confer on GSK-3β the ability to recognize
tau proteins, suggesting that Wnt signalling may link
both amyloid plaque biogenesis and the neurofibrillary
changes observed in AD brains (15). Thus, dysregula-
tion of Wnt signalling, caused by acute or chronic in-
sults, may result in increased GSK-3β activity with en-
suing neuronal degeneration (16). Accordingly, lithium,
which is endowed with neuroprotective properties, has
the capacity to inhibit the activity of GSK-3β through the
activation of the AKT survival pathway (17-19). More-
over, the Wnt antagonist Dickkopf-1 (DKK-1), which po -
tently inhibits the Wnt/β-catenin signalling by linking the
LPR co-receptor, is a transcriptional target of p53 and
functions as a pro-apoptotic gene (20). Thus, a vast ar-
ray of signals converging on GSK-3β may influence
neuronal fate.
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Points of convergence
All these observations uncover an intriguing connection
between development and cell death pathways that
needs to be investigated further and suggest that it may
be possible to identify a cluster of new cell-death mole-
cular protagonists among the proteins involved in neu-
ronal differentiation (21).
We suggest a possible involvement of three pathways
known to be active participants in neuronal maturation
(those involving Notch, Reelin, and Wnt intracellular
signalling) in the neurodegenerative programme acti-
vated by APP proteolysis and/or in the pathogenesis of
NFTs. The focus on the three above-mentioned intra-
cellular pathways is justified by the observation that
there exist several points of convergence (summarized
schematically in figure 1) between these systems and
the APP processing.
PSs, in particular PS1 appear to be key enzymes link-
ing many of the players considered in this review. Gene
knockout studies revealed that PS1 is required for the
proteolytic processing of APP and Notch. The pheno-
type of PS1 knockout mice resembles that of Notch1
knockout mice and the expression of Notch1 and its lig-
and Delta-like1 is diminished in the paraxial mesoderm
of PS1 null embryos. In addition, PS1 has been shown
to interact with β-catenin and Wnt signalling. Wnt sig-
nalling is indeed tightly controlled by, among other
things, cytosolic β-catenin levels. In the absence of Wnt
ligands, cytosolic β-catenin is in fact rapidly phosphory-
lated by GSK-3β. On the contrary, binding of Wnt lig-
ands to cell surface receptors leads to the inactivation
of GSK-3β. It should be noted that GSK-3β is one of the
factors most likely to prove responsible for tau hyper-
phosphorylation. The Reelin signalling pathway in-
volves membrane receptors belonging to the family of
lipoprotein receptors, i.e., VLDL-R and ApoE-R2 (the
latter also being the receptor for apolipoprotein E).
Binding of Reelin to VLDL-R and ApoE-R2 induces acti-
vation of the cdk5/p35 pathway, which is another impor-
tant mediator of tau phosphorylation. Mutation of Reelin
or ApoE-R2 and VLDL-R also induces hyperphosphory-
lation of tau. Finally, double-transgenic mice that ex-
press both human mutant APP and human mutant PS1
show accumulation of Reelin in AD-associated amyloid
plaques.
Another point of convergence is the Abl/Dab complex.
In fact, APP, Reelin and Notch intracellular signalling
require the cytosolic adaptor protein Dab and the tyro-
sine kinase Abl for the transduction of their correspond-
ing intracellular signals. Thus, it is conceivable that al-
teration of one pathway may disrupt the efficiency of
the others.
Concluding remarks
In summary, we believe that the Notch/Reelin/Wnt sig-
nalling pathways and APP processing and toxicity may
influence each other at several and different levels, and
that cross-talk should constitute the basis for detailed
study of the relationship between the processes of neu-
rodevelopment and neurodegeneration. Although it is un-
likely that Reelin, Notch and Wnt are “Alzheimer genes”
(given the lack of linkage between AD and the chromo-
somic regions where these genes are located), all of
them could well play a role in the processing of APP or in
modifying the phosphorylation state of tau proteins.
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F i g u r e 1 - Proteins and signalling pathways implicated in neuronal development and Alzheimer’s disease.
Expectations generated by this hypothesis are twofold,
conceptual and operational. Conceptually, identification
of a link between two apparently distant physiopatho-
logical processes (i.e., neurodevelopment and neurode-
generation) may provide new perspectives from which
to view AD pathophysiology, for instance in terms of ab -
normal reactivation of silent genetic programmes, and
reveal new physiological roles for development-associ-
ated intracellular pathways in the mature brain. From
an operational point of view, a connection between
these pathways may provide a novel framework for the
development of innovative therapeutic interventions in
AD. Pharmacological modulations of Notch/Wnt/Reelin
intracellular signalling pathways may indeed represent
challenging new avenues in the regulation of APP pro-
cessing and tau phosphorylation.
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